0 Items
Select Page

Yellow Fever Virus NS1 Protein

$347.20$1,489.55 excl. VAT

Recombinant Yellow Fever Virus NS1 protein produced in mammalain HEK293 human cells, incorporating a C-terminal 6x His-tag. Greater than 95% purity.

SDS-PAGE: Non-reducing SDS-PAGE showing recombinant YFV NS1 protein.

Yellow Fever Virus NS1 protein

Yellow Fever Virus NS1 protein is produced entirely from human cell lines using state-of-the-art expression techniques, the same approach which NAC used to develop its well received Dengue Virus NS1 serotypes and West Nile Virus NS1 protein. The Yellow Fever Virus NS1 protein is a native hexameric presentation. The hexamer is believed to be the biologically active form of NS1 involved in key aspects of yellow fever pathogenesis. The resultant Yellow Fever Virus NS1 protein is purified to a high degree, is in its native folding state, and possesses all posttranslational modifications. This advanced approach results in a product which delivers optimal antigenicity due to its human origin. The Yellow Fever Virus NS1 protein has been manufactured in response to the unmet need for a highly purified, concentrated protein for use in further vaccine development and serological based diagnostic assays. The detection of the NS1 protein offers much higher fidelity across multiple flaviviruses where cross-reactivity can otherwise pose an issue. Yellow fever continues to be a public health concern inmany countries of Africa and the Americas. It is estimated that 200 000 cases and 30 000 deaths are attributable to yellow fever annually.

****SHIPPING NOTIFICATION: All NS1 products are shipped at ambient temperature. Extensive stability tests have shown no negative effects on antigen performance for 7 days of shipping. Should customers desire shipment on dry ice, this can be performed for an extra fee, please get in contact with us by phone or email.****

Certificate of analysis
Safety Datasheet

Publishing research using our reagents? Please let us know so that we can cite your publication as a reference.

  • Nascimento EJM et al. (2018). Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus. J Virol Methods. 2018 Mar 19;257:48-57. PMID: 2956751
  • Yen CW et al (2015). Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses. Lab Chip.7;15(7):1638-41. PMID: 25672590

You may also like…

Join our mailing list

* indicates required